# of Displayed Technologies: 1 / 1

Applied Category Filter (Click To Remove): Cell Therapy


Categories

OSU-185: first humanized proximal CD30-targeting CAR-T for durable remission in refract. lymphomas
TS-075162 — THE PROBLEM Despite advances in classical Hodgkin’s Lymphoma (cHL) treatment, significant challenges persist with up to 40% of patients relapsing after first-line therapy and 50% after autologous stem cell transplant (aSCT). Current therapies like brentuximab vedotin and checkpoint inhibitors…
  • College: College of Medicine (COM)
  • Inventors: Denlinger, Nathan; Chan, Wing Keung
  • Licensing Officer: He, Panqing

Loading icon